We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Top Stock Picks for the Week of October 16th
NVIDIA Corporation (NVDA - Free Report) ), focuses on personal computer (PC) graphics, graphics processing unit (GPU) and also on artificial intelligence (AI). This #1, Strong Buy has a positive record of earnings surprises in recent quarters. That has helped NVIDIA outperform its industry from a price performance perspective. The company’s sustained efforts toward attaining a robust position in several emerging industries, including Artificial Intelligence, makes analysts optimistic on its growth prospects.
Applied Materials, Inc. (AMAT - Free Report) ), is one of the world’s largest suppliers of fabrication equipment to semiconductor, LCD and solar PV cell manufacturers. It’s been an industry leader for over 20 years. The company just turned in its best quarter in its 50 year history. With excellent results for Q3 and FY 2017, it beat estimates on both its top and bottom lines. This company enjoys multiple growth drivers.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.
See these buy recommendations now >>